TRIB - トリニティ・バイオテック (Trinity Biotech plc)

TRIBのニュース

   Trinity Biotech Plc - ADR Shares Close in on 52-Week Low - Market Mover  2022/01/09 10:42:45 Kwhen Finance
Trinity Biotech Plc - ADR (TRIB) shares closed today at 0.8% above its 52 week low of $1.30, giving the company a market cap of $27M. The stock is currently down 8.4% year-to-date, down 67.2% over the past 12 months, and down 80.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 73.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 3.0% The company's stock price performance over the past 12 months lags the peer average by 511.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Trinity Biotech Plc - ADR Shares Fall 5.1% Below Previous 52-Week Low - Market Mover  2022/01/08 04:21:45 Kwhen Finance
Trinity Biotech Plc - ADR (TRIB) shares closed 5.1% lower than its previous 52 week low, giving the company a market cap of $28M. The stock is currently down 3.5% year-to-date, down 67.9% over the past 12 months, and down 79.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 73.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 6.1% lower than its 5-day moving average, 14.9% lower than its 20-day moving average, and 33.9% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -49.2% The company's stock price performance over the past 12 months lags the peer average by 750.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Trinity Biotech (NASDAQ:TRIB) Downgraded to D- at TheStreet  2021/12/24 06:44:42 Dakota Financial News
TheStreet downgraded shares of Trinity Biotech (NASDAQ:TRIB) from a c- rating to a d- rating in a report published on Monday, TheStreetRatingsTable reports. TRIB stock opened at $1.58 on Monday. The companys 50-day simple moving average is $1.88 and its 200 day simple moving average is $2.26. Trinity Biotech has a 52 week low of []
   Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Companys Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes  2021/12/15 23:21:00 Intrado Digital Media
DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the Company), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2021, the entry into a $81.25million loan facility to refinance the existing $99.9million of exchangeable senior notes issued by the Companys subsidiary, Trinity Biotech Investment Limited (the Notes), and exchange agreements for over 99.7% of the outstanding Notes, all subject to certain conditions precedent.
   Global Point of care Diagnostics Market Size [2021-2028] | to Reach USD 36.21 Billion by 2028  2021/12/07 08:52:00 Intrado Digital Media
Key Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players Key Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.
   POC Diagnostics Market Size is Projected to Reach USD 36.21 Billion by 2028  2021/09/27 11:36:00 Intrado Digital Media
Top Players Covered in the POC Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players Top Players Covered in the POC Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.
   Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth And Change To 2030  2021/09/27 10:40:00 Intrado Digital Media
Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, Hycor Biomedical, Euroimmun AG, and Aesku Group GMBH & CO. Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, Hycor Biomedical, Euroimmun AG, and Aesku Group GMBH & CO.
   Adult Hemoglobinopathy Testing Market See Huge Growth by 2028 | PerkinElmer, Inc., Streck, Inc., Thermo Fisher Scientific, Inc., Trinity Biotech PLC  2021/09/23 11:53:03 OpenPR
Global Adult Hemoglobinopathy Testing Market is estimated to be worth USD 430 Million by 2028, expanding at a CAGR of +3% during 2021-2028. The Global analytical report titled Adult Hemoglobinopathy Testing Market has been recently published by Market Research Inc to
   Hemoglobin A1c Testing Devices Market Size & Demand, Top key players: Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Tosoh, Trinity Biotech, Roche  2021/09/22 08:58:11 OpenPR
Eternity Insights new report provides the reader with an exhaustive study of the Hemoglobin A1c Testing Devices market. the global Hemoglobin A1c Testing Devices market is projected to reach a market. A major portion of the report deals with the
   POC Diagnostics Market worth USD 81.37 Billion at 9.4% by 2028 Backed by Increasing Investment in Development of POC Kits in Europe, reports Fortune Business Insights  2021/09/16 06:57:00 Intrado Digital Media
Key Prominent Players Covered in the POC Diagnostics Market Research Report Are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, BD, bioMérieux SA, Cardinal Health, Inc., Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories Inc, Other Players Key Prominent Players Covered in the POC Diagnostics Market Research Report Are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, BD, bioMérieux SA, Cardinal Health, Inc., Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories Inc, Other Players
   Infectious Disease Diagnostics Market Report 2021: Disruptive Technologies will Drive the Growth of the Industry | Top Key Players-Danaher, Roche Ltd, Trinity Biotech, Bio-Rad, AccuBioTech, ACON, and more  2021/06/04 07:16:21 OpenPR
A Latest intelligence report published by The Insight Partners with title Infectious Disease Diagnostics Market Outlook to 2027. A detailed study accumulated to offer Latest insights about acute features of the Infectious Disease Diagnostics Market. This report provides a detailed
   Analysts Are Revising Their Forecasts NASDAQ:TRIB, NASDAQ:SJ, NASDAQ:TITN, NASDAQ:CRMT  2021/05/29 22:15:00 Stock Market Daily
Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis The post Analysts Are Revising Their Forecasts NASDAQ:TRIB, NASDAQ:SJ, NASDAQ:TITN, NASDAQ:CRMT appeared first on .
   Trinity Biotech plc (TRIB) CEO Ronan O''Caoimh on Q1 2021 Results - Earnings Call Transcript  2021/05/25 18:13:05 Seeking Alpha
   Trinity Biotech slides 7% on Q1 results  2021/05/25 15:04:21 Seeking Alpha
   Trinity Biotech EPS beats by $0.04, beats on revenue  2021/05/25 12:53:37 Seeking Alpha

calendar